Evidence map›Paper›PMID 29670169›Full record

ArticleScientific reports2018

Perineuronal Net Protein Neurocan Inhibits NCAM/EphA3 Repellent Signaling in GABAergic Interneurons.

Chelsea S Sullivan, Ingo Gotthard, Elliott V Wyatt, Srihita Bongu, Vishwa Mohan, Richard J Weinberg, Patricia F Maness

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Hyalectanase Activities by the ADAMTS Metalloproteases.International journal of molecular sciences · 2021
    Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Chelsea S SullivanDepartment of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, 27599, United States.
Ingo GotthardDepartment of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, 27599, United States.
Elliott V WyattDepartment of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, 27599, United States.
Srihita BonguDepartment of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, 27599, United States.
Vishwa MohanDepartment of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, 27599, United States.
Richard J WeinbergDepartment of Cell Biology and Physiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, 27599, United States.
Patricia F ManessDepartment of Biochemistry and Biophysics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, 27599, United States. srclab@med.unc.edu.
University of North Carolina at Chapel Hill · US

Funding

RESEARCH TRAINING IN THE NEUROSCIENCEST32NS007431 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Juan Song, Mark J. Zylka · 1997 to 2026
$10.0M
The Supramolecular Architecture of the Postsynaptic DensityR01NS039444 · NINDS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI WEINBERG, RICHARD J · 2000 to 2021
$6.1M
Molecular Mechanisms of Inhibitory Circuit DevelopmentR01MH101605 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MANESS, PATRICIA F · 2014 to 2018
$1.9M
Mechanisms of Synapse Remodeling of Cortical GABAergic InterneuronsF32MH111189 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SULLIVAN, CHELSEA SUZANNE · 2016 to 2017
$105k
NIMH NIH HHS F32 MH111189NIMH NIH HHS R01 MH101605NINDS NIH HHS R01 NS039444NINDS NIH HHS T32 NS007431
6 · The paper itself

Abstract

Perineuronal nets (PNNs) are implicated in closure of critical periods of synaptic plasticity in the brain, but the molecular mechanisms by which PNNs regulate synapse development are obscure. A receptor complex of NCAM and EphA3 mediates postnatal remodeling of inhibitory perisomatic synapses of GABAergic interneurons onto pyramidal cells in the mouse frontal cortex necessary for excitatory/inhibitory balance. Here it is shown that enzymatic removal of PNN glycosaminoglycan chains decreased the density of GABAergic perisomatic synapses in mouse organotypic cortical slice cultures. Neurocan, a key component of PNNs, was expressed in postnatal frontal cortex in apposition to perisomatic synapses of parvalbumin-positive interneurons. Polysialylated NCAM (PSA-NCAM), which is required for ephrin-dependent synapse remodeling, bound less efficiently to neurocan than mature, non-PSA-NCAM. Neurocan bound the non-polysialylated form of NCAM at the EphA3 binding site within the immunoglobulin-2 domain. Neurocan inhibited NCAM/EphA3 association, membrane clustering of NCAM/EphA3 in cortical interneuron axons, EphA3 kinase activation, and ephrin-A5-induced growth cone collapse. These studies delineate a novel mechanism wherein neurocan inhibits NCAM/EphA3 signaling and axonal repulsion, which may terminate postnatal remodeling of interneuron axons to stabilize perisomatic synapses in vivo.

Indexed as

Signal TransductionAnimalsCerebral CortexGABAergic NeuronsHumansInterneuronsMiceNeural Cell Adhesion MoleculesNeurocanProtein BindingProtein Interaction Domains and MotifsReceptor, EphA3Receptor Protein-Tyrosine KinasesEPHA3 protein, humanNeural Cell Adhesion MoleculesNeurocanReceptor, EphA3Receptor Protein-Tyrosine Kinases

Identifiers

PMID29670169
PMCPMC5906663
OpenAlexW2801644687

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.